Volume 19, Number 9—September 2013
CME ACTIVITY - Research
Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA
Amy Parker Fiebelkorn
, Jacqueline Lawler, Aaron T. Curns, Christina Brandeburg, and Gregory S. Wallace
, Jacqueline Lawler, Aaron T. Curns, Christina Brandeburg, and Gregory S. Wallace
Table 1
Characteristics of index case-patients with mumps, Orange County, New York, 2009–2010*
| Characteristic | No. (%) |
|---|---|
| Age. y | |
| Median (range) | 9 (1–39) |
| 0–3 | 3 (6.1) |
| 4–6 | 8 (16.3) |
| 7–17 | 27 (55.1) |
| >18 |
11 (22.4) |
| Sex | |
| F | 24 (49.0) |
| M |
25 (51.0) |
| No. MMR doses | |
| 0 | 11 (22.4) |
| 1 | 5 (10.2) |
| 2 | 32 (65.3) |
| 3 | 1 (2.0)† |
| >1 | 38 (77.6) |
| Median interval (range) since last dose, mo | 47 (3–170) |
*MMR, measles-mumps-rubella vaccine; values are in no. (%) unless otherwise indicated.
†Person received a third MMR does in January 2010 prior to parotitis onset in February 2010. This person did not receive the third dose as part of the study.
Page created: August 23, 2013
Page updated: August 23, 2013
Page reviewed: August 23, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.